

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 6.82329896 |
| 2 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 6.82329896 |
| 3 | neutrophil mediated immunity (GO:0002446) | 6.56636941 |
| 4 | negative regulation of phagocytosis (GO:0050765) | 6.13803574 |
| 5 | proteasome assembly (GO:0043248) | 5.82204464 |
| 6 | DNA deamination (GO:0045006) | 5.76582471 |
| 7 | defense response to fungus (GO:0050832) | 5.52385402 |
| 8 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 5.42449818 |
| 9 | regulation of growth of symbiont in host (GO:0044126) | 5.42449818 |
| 10 | negative regulation of growth of symbiont in host (GO:0044130) | 5.42449818 |
| 11 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 5.42449818 |
| 12 | myeloid leukocyte mediated immunity (GO:0002444) | 5.39158587 |
| 13 | response to fungus (GO:0009620) | 5.22033957 |
| 14 | disruption of cells of other organism (GO:0044364) | 5.12996077 |
| 15 | killing of cells of other organism (GO:0031640) | 5.12996077 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 4.98088524 |
| 17 | cullin deneddylation (GO:0010388) | 4.93505239 |
| 18 | pentose-phosphate shunt (GO:0006098) | 4.86063920 |
| 19 | establishment of integrated proviral latency (GO:0075713) | 4.72712773 |
| 20 | protein deneddylation (GO:0000338) | 4.60577421 |
| 21 | respiratory burst (GO:0045730) | 4.57799363 |
| 22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.54522548 |
| 23 | DNA double-strand break processing (GO:0000729) | 4.54452169 |
| 24 | protein neddylation (GO:0045116) | 4.53473331 |
| 25 | NADPH regeneration (GO:0006740) | 4.52221297 |
| 26 | reactive oxygen species biosynthetic process (GO:1903409) | 4.42242125 |
| 27 | ribonucleoprotein complex disassembly (GO:0032988) | 4.20817610 |
| 28 | establishment of viral latency (GO:0019043) | 4.12032578 |
| 29 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.11069743 |
| 30 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.10806683 |
| 31 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.02907589 |
| 32 | cellular response to zinc ion (GO:0071294) | 4.01747063 |
| 33 | cotranslational protein targeting to membrane (GO:0006613) | 3.99520453 |
| 34 | protein targeting to ER (GO:0045047) | 3.98882037 |
| 35 | organelle disassembly (GO:1903008) | 3.96375429 |
| 36 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.90771411 |
| 37 | leukocyte mediated cytotoxicity (GO:0001909) | 3.89925719 |
| 38 | signal peptide processing (GO:0006465) | 3.86876488 |
| 39 | protein localization to endoplasmic reticulum (GO:0070972) | 3.85649411 |
| 40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.79854678 |
| 41 | CENP-A containing nucleosome assembly (GO:0034080) | 3.79358340 |
| 42 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.77652979 |
| 43 | viral transcription (GO:0019083) | 3.75616571 |
| 44 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.74363428 |
| 45 | neutrophil activation involved in immune response (GO:0002283) | 3.73084175 |
| 46 | ribosome assembly (GO:0042255) | 3.72667051 |
| 47 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.70143983 |
| 48 | translational termination (GO:0006415) | 3.70021369 |
| 49 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.69347806 |
| 50 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.68873973 |
| 51 | negative regulation of ligase activity (GO:0051352) | 3.68126775 |
| 52 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.68126775 |
| 53 | COPI coating of Golgi vesicle (GO:0048205) | 3.63156803 |
| 54 | Golgi transport vesicle coating (GO:0048200) | 3.63156803 |
| 55 | chromatin remodeling at centromere (GO:0031055) | 3.61004038 |
| 56 | regulation of protein heterodimerization activity (GO:0043497) | 3.51845160 |
| 57 | DNA strand elongation (GO:0022616) | 3.49386984 |
| 58 | protein maturation by protein folding (GO:0022417) | 3.49023825 |
| 59 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.46400145 |
| 60 | DNA damage response, detection of DNA damage (GO:0042769) | 3.45837892 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.44141686 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.44141686 |
| 63 | 7-methylguanosine mRNA capping (GO:0006370) | 3.42016238 |
| 64 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.39322361 |
| 65 | sequestering of actin monomers (GO:0042989) | 3.39302995 |
| 66 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.38066613 |
| 67 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.37020661 |
| 68 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.36811388 |
| 69 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.35496697 |
| 70 | actin nucleation (GO:0045010) | 3.35024565 |
| 71 | 7-methylguanosine RNA capping (GO:0009452) | 3.31005804 |
| 72 | RNA capping (GO:0036260) | 3.31005804 |
| 73 | ATP synthesis coupled proton transport (GO:0015986) | 3.29978391 |
| 74 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.29978391 |
| 75 | translational elongation (GO:0006414) | 3.28472744 |
| 76 | angiotensin maturation (GO:0002003) | 3.28256067 |
| 77 | glucose catabolic process (GO:0006007) | 3.27694507 |
| 78 | chaperone-mediated protein transport (GO:0072321) | 3.25415743 |
| 79 | formation of translation preinitiation complex (GO:0001731) | 3.24101628 |
| 80 | positive regulation of ligase activity (GO:0051351) | 3.23922261 |
| 81 | de novo protein folding (GO:0006458) | 3.23651523 |
| 82 | positive regulation of mitochondrial fission (GO:0090141) | 3.22731916 |
| 83 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.21309833 |
| 84 | telomere maintenance via recombination (GO:0000722) | 3.19517750 |
| 85 | protein K11-linked ubiquitination (GO:0070979) | 3.18518635 |
| 86 | protein targeting to mitochondrion (GO:0006626) | 3.18517156 |
| 87 | termination of RNA polymerase III transcription (GO:0006386) | 3.18258059 |
| 88 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.18258059 |
| 89 | sequestering of metal ion (GO:0051238) | 3.17240085 |
| 90 | mitotic metaphase plate congression (GO:0007080) | 3.15560617 |
| 91 | histone mRNA metabolic process (GO:0008334) | 3.14644066 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.14520655 |
| 93 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.13797787 |
| 94 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.13111759 |
| 95 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.10919898 |
| 96 | protein localization to mitochondrion (GO:0070585) | 3.09259899 |
| 97 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.08280809 |
| 98 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.08280809 |
| 99 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.08280809 |
| 100 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.07605206 |
| 101 | de novo posttranslational protein folding (GO:0051084) | 3.07592612 |
| 102 | pentose metabolic process (GO:0019321) | 3.07072235 |
| 103 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.07034565 |
| 104 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.07034565 |
| 105 | regulation of coenzyme metabolic process (GO:0051196) | 3.07021012 |
| 106 | regulation of cofactor metabolic process (GO:0051193) | 3.07021012 |
| 107 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.05106191 |
| 108 | ribosomal large subunit biogenesis (GO:0042273) | 2.99715896 |
| 109 | regulation of ligase activity (GO:0051340) | 2.99149835 |
| 110 | histone exchange (GO:0043486) | 2.98265240 |
| 111 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.98043341 |
| 112 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.97079529 |
| 113 | maturation of 5.8S rRNA (GO:0000460) | 2.96408694 |
| 114 | response to peptidoglycan (GO:0032494) | 2.96041808 |
| 115 | DNA replication initiation (GO:0006270) | 2.94744638 |
| 116 | rRNA modification (GO:0000154) | 2.93692896 |
| 117 | oxidative phosphorylation (GO:0006119) | 2.93137387 |
| 118 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.92899999 |
| 119 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.92899999 |
| 120 | platelet dense granule organization (GO:0060155) | 2.90362890 |
| 121 | DNA unwinding involved in DNA replication (GO:0006268) | 2.89899987 |
| 122 | spliceosomal snRNP assembly (GO:0000387) | 2.89704690 |
| 123 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.88951307 |
| 124 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.86844560 |
| 125 | cellular protein complex disassembly (GO:0043624) | 2.86253199 |
| 126 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.85928794 |
| 127 | viral life cycle (GO:0019058) | 2.85680218 |
| 128 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.85586532 |
| 129 | ribosomal small subunit biogenesis (GO:0042274) | 2.85084903 |
| 130 | mitotic recombination (GO:0006312) | 2.84792853 |
| 131 | establishment of protein localization to mitochondrion (GO:0072655) | 2.84692111 |
| 132 | membrane budding (GO:0006900) | 2.84574964 |
| 133 | macrophage differentiation (GO:0030225) | 2.83832590 |
| 134 | translational initiation (GO:0006413) | 2.83629858 |
| 135 | cell killing (GO:0001906) | 2.82955822 |
| 136 | necroptotic process (GO:0070266) | 2.82932131 |
| 137 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.82096636 |
| 138 | respiratory electron transport chain (GO:0022904) | 2.81872728 |
| 139 | glucose 6-phosphate metabolic process (GO:0051156) | 2.81629327 |
| 140 | positive regulation of lamellipodium assembly (GO:0010592) | 2.80822799 |
| 141 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.80298387 |
| 142 | peptidyl-histidine modification (GO:0018202) | 2.78086275 |
| 143 | metaphase plate congression (GO:0051310) | 2.77812114 |
| 144 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.77473351 |
| 145 | positive regulation of actin filament depolymerization (GO:0030836) | 2.74534314 |
| 146 | DNA replication checkpoint (GO:0000076) | 2.74148892 |
| 147 | protein retention in ER lumen (GO:0006621) | 2.73581390 |
| 148 | electron transport chain (GO:0022900) | 2.72165111 |
| 149 | mitochondrial calcium ion transport (GO:0006851) | 2.70868062 |
| 150 | protein heterotetramerization (GO:0051290) | 2.70819494 |
| 151 | protein targeting to membrane (GO:0006612) | 2.69630972 |
| 152 | regulation of sulfur metabolic process (GO:0042762) | 2.69491273 |
| 153 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.68108276 |
| 154 | DNA replication-independent nucleosome organization (GO:0034724) | 2.68108276 |
| 155 | mitotic spindle checkpoint (GO:0071174) | 2.66946472 |
| 156 | negative regulation of protein ubiquitination (GO:0031397) | 2.65061429 |
| 157 | translation (GO:0006412) | 2.64789951 |
| 158 | spindle checkpoint (GO:0031577) | 2.64430421 |
| 159 | protein-cofactor linkage (GO:0018065) | 2.63944731 |
| 160 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63505684 |
| 161 | regulation of mitochondrial translation (GO:0070129) | 2.62780291 |
| 162 | DNA ligation (GO:0006266) | 2.62171223 |
| 163 | maturation of SSU-rRNA (GO:0030490) | 2.61943034 |
| 164 | GTP biosynthetic process (GO:0006183) | 2.61182026 |
| 165 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.60515597 |
| 166 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.60375679 |
| 167 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.59933395 |
| 168 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.59542479 |
| 169 | hydrogen peroxide catabolic process (GO:0042744) | 2.58814010 |
| 170 | non-recombinational repair (GO:0000726) | 2.56307657 |
| 171 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.56307657 |
| 172 | regulation of cellular amine metabolic process (GO:0033238) | 2.56165695 |
| 173 | negative regulation of RNA splicing (GO:0033119) | 2.54849113 |
| 174 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.54797055 |
| 175 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.54797055 |
| 176 | telomere maintenance via telomere lengthening (GO:0010833) | 2.54174827 |
| 177 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.51916279 |
| 178 | heme biosynthetic process (GO:0006783) | 2.51071566 |
| 179 | protein complex disassembly (GO:0043241) | 2.50371086 |
| 180 | purine-containing compound salvage (GO:0043101) | 2.49648926 |
| 181 | L-fucose catabolic process (GO:0042355) | 2.48198742 |
| 182 | fucose catabolic process (GO:0019317) | 2.48198742 |
| 183 | L-fucose metabolic process (GO:0042354) | 2.48198742 |
| 184 | mast cell activation (GO:0045576) | 2.47698692 |
| 185 | cellular response to interferon-beta (GO:0035458) | 2.45219792 |
| 186 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.43973564 |
| 187 | regulation of chemokine biosynthetic process (GO:0045073) | 2.43541506 |
| 188 | positive regulation of B cell differentiation (GO:0045579) | 2.41225873 |
| 189 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40324284 |
| 190 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.39919092 |
| 191 | pseudouridine synthesis (GO:0001522) | 2.39555037 |
| 192 | IMP metabolic process (GO:0046040) | 2.38438203 |
| 193 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.37840766 |
| 194 | response to interferon-beta (GO:0035456) | 2.37750405 |
| 195 | macromolecular complex disassembly (GO:0032984) | 2.37692501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.50345045 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.11313670 |
| 3 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.25529344 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.16873559 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78221256 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.71712616 |
| 7 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.71361183 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.68111923 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.59182207 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.58513023 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.56420849 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.55198559 |
| 13 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35939547 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29463013 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.28605920 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.28156345 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.20471355 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.20421332 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19831707 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.16587629 |
| 21 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.15308137 |
| 22 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15251747 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.12397462 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.12309242 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10083225 |
| 26 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.06768388 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 2.05607807 |
| 28 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.04497197 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01126964 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.99743779 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.99649187 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99550137 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.98074045 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97006023 |
| 35 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96898467 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.96494086 |
| 37 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.96291879 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.94904343 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94009910 |
| 40 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.93886889 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92873993 |
| 42 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.91659700 |
| 43 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.90902635 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.88683888 |
| 45 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.86770907 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86026707 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.84102567 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83361148 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81589857 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.78379707 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.78077867 |
| 52 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.77857040 |
| 53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76734133 |
| 54 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.73965360 |
| 55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.72581514 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.71154419 |
| 57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.70558572 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69730481 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69289184 |
| 60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.68459989 |
| 61 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.65206210 |
| 62 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.63648420 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63017508 |
| 64 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.62383731 |
| 65 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.62308769 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.61084558 |
| 67 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.59380187 |
| 68 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.58478457 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.58414347 |
| 70 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.57065589 |
| 71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54928759 |
| 72 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.54140613 |
| 73 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.53280942 |
| 74 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.52631691 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50717318 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49840698 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43116597 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43051073 |
| 79 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.40384255 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40357206 |
| 81 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.39503046 |
| 82 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38446448 |
| 83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38198713 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38043172 |
| 85 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37616335 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36391728 |
| 87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.35773796 |
| 88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.34430779 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33482406 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32729850 |
| 91 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31404581 |
| 92 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30710595 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30500054 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27709222 |
| 95 | MYB_26560356_Chip-Seq_TH1_Human | 1.27270160 |
| 96 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.26838427 |
| 97 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24497401 |
| 98 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.24355206 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 1.23295458 |
| 100 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23151015 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22624836 |
| 102 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22395152 |
| 103 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.21859687 |
| 104 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.20349858 |
| 105 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19998017 |
| 106 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18042729 |
| 107 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.17512700 |
| 108 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16797913 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15160791 |
| 110 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13996739 |
| 111 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13454870 |
| 112 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13244143 |
| 113 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.12880469 |
| 114 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12484125 |
| 115 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.11791975 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10933261 |
| 117 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.10623766 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10192967 |
| 119 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08334834 |
| 120 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07901494 |
| 121 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06251020 |
| 122 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06010928 |
| 123 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05987583 |
| 124 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01908712 |
| 125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00601222 |
| 126 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.00083309 |
| 127 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.99758552 |
| 128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99460672 |
| 129 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97427818 |
| 130 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97085833 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96892540 |
| 132 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96638673 |
| 133 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.96210358 |
| 134 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96019001 |
| 135 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95531737 |
| 136 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.95388002 |
| 137 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94100458 |
| 138 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93968274 |
| 139 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93631720 |
| 140 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.92358428 |
| 141 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.91510869 |
| 142 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91450025 |
| 143 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90385447 |
| 144 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90152340 |
| 145 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89298549 |
| 146 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89247011 |
| 147 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.88169528 |
| 148 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86667585 |
| 149 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83153209 |
| 150 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82860564 |
| 151 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82033810 |
| 152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81125328 |
| 153 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81125328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.49036203 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.35731192 |
| 3 | MP0009697_abnormal_copulation | 3.33109762 |
| 4 | MP0003436_decreased_susceptibility_to | 3.26149103 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.84042475 |
| 6 | MP0003724_increased_susceptibility_to | 2.80312874 |
| 7 | MP0002419_abnormal_innate_immunity | 2.77113750 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.72243757 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.70099278 |
| 10 | MP0001529_abnormal_vocalization | 2.66509158 |
| 11 | MP0008932_abnormal_embryonic_tissue | 2.59899159 |
| 12 | MP0009785_altered_susceptibility_to | 2.58136726 |
| 13 | MP0003718_maternal_effect | 2.53975516 |
| 14 | MP0005025_abnormal_response_to | 2.42444409 |
| 15 | MP0003941_abnormal_skin_development | 2.42302298 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.41785993 |
| 17 | MP0001188_hyperpigmentation | 2.29333410 |
| 18 | MP0002006_tumorigenesis | 2.26792104 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.26630507 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 2.19314052 |
| 21 | MP0000858_altered_metastatic_potential | 2.18228766 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.17621261 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.17245048 |
| 24 | MP0005174_abnormal_tail_pigmentation | 2.14693608 |
| 25 | MP0000490_abnormal_crypts_of | 2.13277738 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 2.13031554 |
| 27 | MP0001545_abnormal_hematopoietic_system | 2.13031554 |
| 28 | MP0003172_abnormal_lysosome_physiology | 2.12514294 |
| 29 | MP0006054_spinal_hemorrhage | 2.12478017 |
| 30 | MP0004272_abnormal_basement_membrane | 2.05816722 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.98099952 |
| 32 | MP0005671_abnormal_response_to | 1.97573661 |
| 33 | MP0002102_abnormal_ear_morphology | 1.96413056 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 1.95614477 |
| 35 | MP0001819_abnormal_immune_cell | 1.95306904 |
| 36 | MP0003011_delayed_dark_adaptation | 1.93322954 |
| 37 | MP0003786_premature_aging | 1.90953697 |
| 38 | MP0001542_abnormal_bone_strength | 1.89101134 |
| 39 | MP0002398_abnormal_bone_marrow | 1.88514270 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.88260408 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.87490141 |
| 42 | MP0000516_abnormal_urinary_system | 1.81829058 |
| 43 | MP0005367_renal/urinary_system_phenotyp | 1.81829058 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.80341525 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.79152345 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.75236372 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.74225905 |
| 48 | MP0000647_abnormal_sebaceous_gland | 1.73118793 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.71379170 |
| 50 | MP0001293_anophthalmia | 1.69646931 |
| 51 | MP0001853_heart_inflammation | 1.69617856 |
| 52 | MP0000716_abnormal_immune_system | 1.69346613 |
| 53 | MP0002723_abnormal_immune_serum | 1.69210619 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.68620545 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.68157136 |
| 56 | MP0002234_abnormal_pharynx_morphology | 1.67251905 |
| 57 | MP0003950_abnormal_plasma_membrane | 1.66709206 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.66519371 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.66344238 |
| 60 | MP0000685_abnormal_immune_system | 1.65514594 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.64978794 |
| 62 | MP0003186_abnormal_redox_activity | 1.63847963 |
| 63 | MP0000343_altered_response_to | 1.62463580 |
| 64 | MP0003880_abnormal_central_pattern | 1.62064055 |
| 65 | MP0002405_respiratory_system_inflammati | 1.56595283 |
| 66 | MP0002429_abnormal_blood_cell | 1.56550116 |
| 67 | MP0002722_abnormal_immune_system | 1.55192128 |
| 68 | MP0002233_abnormal_nose_morphology | 1.54827183 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.54521657 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.51245477 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.50401745 |
| 72 | MP0001800_abnormal_humoral_immune | 1.49334722 |
| 73 | MP0003077_abnormal_cell_cycle | 1.48727408 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.47289317 |
| 75 | MP0005187_abnormal_penis_morphology | 1.46191307 |
| 76 | MP0005275_abnormal_skin_tensile | 1.46183279 |
| 77 | MP0010307_abnormal_tumor_latency | 1.45272102 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.44390375 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 1.44105148 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 1.42346796 |
| 81 | MP0002090_abnormal_vision | 1.42219237 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 1.39044877 |
| 83 | MP0010155_abnormal_intestine_physiology | 1.38528428 |
| 84 | MP0001873_stomach_inflammation | 1.36544782 |
| 85 | MP0002019_abnormal_tumor_incidence | 1.35511303 |
| 86 | MP0008469_abnormal_protein_level | 1.33745766 |
| 87 | MP0002736_abnormal_nociception_after | 1.30316474 |
| 88 | MP0002282_abnormal_trachea_morphology | 1.30057908 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 1.25517006 |
| 90 | MP0002160_abnormal_reproductive_system | 1.25267158 |
| 91 | MP0003385_abnormal_body_wall | 1.25047377 |
| 92 | MP0005623_abnormal_meninges_morphology | 1.24241452 |
| 93 | MP0003937_abnormal_limbs/digits/tail_de | 1.20390285 |
| 94 | MP0003567_abnormal_fetal_cardiomyocyte | 1.20313182 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 1.20181154 |
| 96 | MP0000703_abnormal_thymus_morphology | 1.19741828 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 1.16611790 |
| 98 | MP0001663_abnormal_digestive_system | 1.16090051 |
| 99 | MP0000015_abnormal_ear_pigmentation | 1.15868700 |
| 100 | MP0001984_abnormal_olfaction | 1.15435745 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 1.10958177 |
| 102 | MP0001790_abnormal_immune_system | 1.10788989 |
| 103 | MP0005387_immune_system_phenotype | 1.10788989 |
| 104 | MP0000049_abnormal_middle_ear | 1.10608577 |
| 105 | MP0002751_abnormal_autonomic_nervous | 1.10435531 |
| 106 | MP0001697_abnormal_embryo_size | 1.08963998 |
| 107 | MP0008057_abnormal_DNA_replication | 1.08665009 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 1.08110998 |
| 109 | MP0005220_abnormal_exocrine_pancreas | 1.08026752 |
| 110 | MP0000372_irregular_coat_pigmentation | 1.06609354 |
| 111 | MP0003448_altered_tumor_morphology | 1.06020382 |
| 112 | MP0005164_abnormal_response_to | 1.05090614 |
| 113 | MP0001177_atelectasis | 1.04934706 |
| 114 | MP0008007_abnormal_cellular_replicative | 1.04783782 |
| 115 | MP0004215_abnormal_myocardial_fiber | 1.03036780 |
| 116 | MP0000358_abnormal_cell_content/ | 1.02477995 |
| 117 | MP0002970_abnormal_white_adipose | 1.01841646 |
| 118 | MP0001730_embryonic_growth_arrest | 0.99990192 |
| 119 | MP0002177_abnormal_outer_ear | 0.99745590 |
| 120 | MP0001879_abnormal_lymphatic_vessel | 0.99505895 |
| 121 | MP0003890_abnormal_embryonic-extraembry | 0.99280458 |
| 122 | MP0001286_abnormal_eye_development | 0.97374143 |
| 123 | MP0003755_abnormal_palate_morphology | 0.97291292 |
| 124 | MP0005253_abnormal_eye_physiology | 0.96986894 |
| 125 | MP0005501_abnormal_skin_physiology | 0.96881121 |
| 126 | MP0002095_abnormal_skin_pigmentation | 0.96390007 |
| 127 | MP0001881_abnormal_mammary_gland | 0.94148856 |
| 128 | MP0003866_abnormal_defecation | 0.92247015 |
| 129 | MP0008058_abnormal_DNA_repair | 0.91178997 |
| 130 | MP0005394_taste/olfaction_phenotype | 0.90680422 |
| 131 | MP0005499_abnormal_olfactory_system | 0.90680422 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.90585650 |
| 133 | MP0000427_abnormal_hair_cycle | 0.90456876 |
| 134 | MP0005503_abnormal_tendon_morphology | 0.89067788 |
| 135 | MP0001851_eye_inflammation | 0.84988419 |
| 136 | MP0000762_abnormal_tongue_morphology | 0.84900819 |
| 137 | MP0002933_joint_inflammation | 0.84174656 |
| 138 | MP0002084_abnormal_developmental_patter | 0.83998545 |
| 139 | MP0000313_abnormal_cell_death | 0.83842357 |
| 140 | MP0009763_increased_sensitivity_to | 0.83646649 |
| 141 | MP0005257_abnormal_intraocular_pressure | 0.82761325 |
| 142 | MP0002085_abnormal_embryonic_tissue | 0.81351353 |
| 143 | MP0005360_urolithiasis | 0.80802584 |
| 144 | MP0003075_altered_response_to | 0.80543758 |
| 145 | MP0002693_abnormal_pancreas_physiology | 0.79926309 |
| 146 | MP0005076_abnormal_cell_differentiation | 0.79827312 |
| 147 | MP0002971_abnormal_brown_adipose | 0.79578939 |
| 148 | MP0002210_abnormal_sex_determination | 0.79571014 |
| 149 | MP0003121_genomic_imprinting | 0.79076517 |
| 150 | MP0001672_abnormal_embryogenesis/_devel | 0.79000583 |
| 151 | MP0005380_embryogenesis_phenotype | 0.79000583 |
| 152 | MP0008873_increased_physiological_sensi | 0.78843608 |
| 153 | MP0005389_reproductive_system_phenotype | 0.78421749 |
| 154 | MP0003315_abnormal_perineum_morphology | 0.78285974 |
| 155 | MP0009250_abnormal_appendicular_skeleto | 0.77651107 |
| 156 | MP0003795_abnormal_bone_structure | 0.77178240 |
| 157 | MP0003123_paternal_imprinting | 0.76331613 |
| 158 | MP0005391_vision/eye_phenotype | 0.76267790 |
| 159 | MP0004782_abnormal_surfactant_physiolog | 0.75368228 |
| 160 | MP0001986_abnormal_taste_sensitivity | 0.75150640 |
| 161 | MP0002938_white_spotting | 0.74547623 |
| 162 | MP0000598_abnormal_liver_morphology | 0.72743282 |
| 163 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71258628 |
| 164 | MP0005390_skeleton_phenotype | 0.71230076 |
| 165 | MP0001727_abnormal_embryo_implantation | 0.71184216 |
| 166 | MP0000653_abnormal_sex_gland | 0.70908679 |
| 167 | MP0000350_abnormal_cell_proliferation | 0.70693094 |
| 168 | MP0003119_abnormal_digestive_system | 0.70554074 |
| 169 | MP0002080_prenatal_lethality | 0.70278678 |
| 170 | MP0001905_abnormal_dopamine_level | 0.70150175 |
| 171 | MP0002060_abnormal_skin_morphology | 0.70060603 |
| 172 | MP0005319_abnormal_enzyme/_coenzyme | 0.70047142 |
| 173 | MP0001764_abnormal_homeostasis | 0.69941532 |
| 174 | MP0010678_abnormal_skin_adnexa | 0.69766328 |
| 175 | MP0005193_abnormal_anterior_eye | 0.69407682 |
| 176 | MP0001340_abnormal_eyelid_morphology | 0.69391024 |
| 177 | MP0002089_abnormal_postnatal_growth/wei | 0.68806448 |
| 178 | MP0000249_abnormal_blood_vessel | 0.68700507 |
| 179 | MP0001243_abnormal_dermal_layer | 0.67244369 |
| 180 | MP0002998_abnormal_bone_remodeling | 0.66520370 |
| 181 | MP0001929_abnormal_gametogenesis | 0.66498617 |
| 182 | MP0003191_abnormal_cellular_cholesterol | 0.66093954 |
| 183 | MP0003252_abnormal_bile_duct | 0.65626496 |
| 184 | MP0002796_impaired_skin_barrier | 0.65305509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 5.43616099 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.57028017 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.42382396 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 4.38168039 |
| 5 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.29770478 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.29139085 |
| 7 | Reduced antithrombin III activity (HP:0001976) | 4.22429221 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 4.16296849 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.05690434 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 4.01409214 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.97059990 |
| 12 | Obstructive lung disease (HP:0006536) | 3.97059990 |
| 13 | Aplastic anemia (HP:0001915) | 3.73315715 |
| 14 | Acute encephalopathy (HP:0006846) | 3.70003513 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.66649215 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.53992841 |
| 17 | Myositis (HP:0100614) | 3.49078354 |
| 18 | Mitochondrial inheritance (HP:0001427) | 3.48698795 |
| 19 | Type I transferrin isoform profile (HP:0003642) | 3.46911839 |
| 20 | Increased CSF lactate (HP:0002490) | 3.45783046 |
| 21 | Papilledema (HP:0001085) | 3.41487643 |
| 22 | Increased serum pyruvate (HP:0003542) | 3.39236506 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.35342190 |
| 24 | Reticulocytopenia (HP:0001896) | 3.28062556 |
| 25 | Abnormality of glycolysis (HP:0004366) | 3.18799532 |
| 26 | Hepatocellular necrosis (HP:0001404) | 3.07723101 |
| 27 | Abnormal protein glycosylation (HP:0012346) | 3.07490090 |
| 28 | Abnormal glycosylation (HP:0012345) | 3.07490090 |
| 29 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.07490090 |
| 30 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.07490090 |
| 31 | Abnormality of the prostate (HP:0008775) | 3.01438420 |
| 32 | Renal Fanconi syndrome (HP:0001994) | 3.01358309 |
| 33 | Petechiae (HP:0000967) | 2.95307754 |
| 34 | Cerebral edema (HP:0002181) | 2.85763379 |
| 35 | Abnormality of the lumbar spine (HP:0100712) | 2.84638649 |
| 36 | Chest pain (HP:0100749) | 2.84092443 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.83715382 |
| 38 | Meningitis (HP:0001287) | 2.79057014 |
| 39 | Increased serum lactate (HP:0002151) | 2.78420281 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.78256662 |
| 41 | Abnormality of the thoracic spine (HP:0100711) | 2.75847661 |
| 42 | Periodontitis (HP:0000704) | 2.74685958 |
| 43 | Thoracic kyphosis (HP:0002942) | 2.73629048 |
| 44 | Abnormality of B cell number (HP:0010975) | 2.72648937 |
| 45 | B lymphocytopenia (HP:0010976) | 2.72648937 |
| 46 | Pulmonary fibrosis (HP:0002206) | 2.66712988 |
| 47 | Posterior subcapsular cataract (HP:0007787) | 2.65141360 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.59470926 |
| 49 | Lactic acidosis (HP:0003128) | 2.59261279 |
| 50 | Recurrent skin infections (HP:0001581) | 2.57812867 |
| 51 | IgM deficiency (HP:0002850) | 2.57019415 |
| 52 | Eosinophilia (HP:0001880) | 2.52982321 |
| 53 | Granulocytopenia (HP:0001913) | 2.49500627 |
| 54 | Thoracolumbar scoliosis (HP:0002944) | 2.48743158 |
| 55 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.48613560 |
| 56 | Cortical dysplasia (HP:0002539) | 2.48508154 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.47922997 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.47059978 |
| 59 | Poor head control (HP:0002421) | 2.46936968 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.44632942 |
| 61 | Chronic otitis media (HP:0000389) | 2.42912864 |
| 62 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.42596308 |
| 63 | J-shaped sella turcica (HP:0002680) | 2.39043709 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.38745786 |
| 65 | Hemoptysis (HP:0002105) | 2.32741093 |
| 66 | Retinal dysplasia (HP:0007973) | 2.31964557 |
| 67 | Recurrent viral infections (HP:0004429) | 2.30062310 |
| 68 | Exercise intolerance (HP:0003546) | 2.29342303 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.28987084 |
| 70 | Abnormality of serum amino acid levels (HP:0003112) | 2.28916716 |
| 71 | Abnormality of the labia minora (HP:0012880) | 2.27981892 |
| 72 | 3-Methylglutaconic aciduria (HP:0003535) | 2.26799161 |
| 73 | Impaired platelet aggregation (HP:0003540) | 2.26439682 |
| 74 | Abnormal platelet function (HP:0011869) | 2.26439682 |
| 75 | Delayed gross motor development (HP:0002194) | 2.26237469 |
| 76 | Short tibia (HP:0005736) | 2.25230964 |
| 77 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.23191921 |
| 78 | Mucopolysacchariduria (HP:0008155) | 2.23191921 |
| 79 | Short middle phalanx of the 5th finger (HP:0004220) | 2.21939175 |
| 80 | Abnormal lung lobation (HP:0002101) | 2.21760555 |
| 81 | Pallor (HP:0000980) | 2.21328802 |
| 82 | Bifid tongue (HP:0010297) | 2.20184459 |
| 83 | Microglossia (HP:0000171) | 2.19657886 |
| 84 | Multiple enchondromatosis (HP:0005701) | 2.19359160 |
| 85 | Medial flaring of the eyebrow (HP:0010747) | 2.18153519 |
| 86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.18091320 |
| 87 | Abnormality of alanine metabolism (HP:0010916) | 2.18091320 |
| 88 | Hyperalaninemia (HP:0003348) | 2.18091320 |
| 89 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.17126995 |
| 90 | Metaphyseal dysplasia (HP:0100255) | 2.16086959 |
| 91 | Nausea (HP:0002018) | 2.14808324 |
| 92 | Epistaxis (HP:0000421) | 2.14207494 |
| 93 | Congenital, generalized hypertrichosis (HP:0004540) | 2.12856744 |
| 94 | Congenital primary aphakia (HP:0007707) | 2.12392066 |
| 95 | Gingivitis (HP:0000230) | 2.11820661 |
| 96 | Oral leukoplakia (HP:0002745) | 2.10171255 |
| 97 | Postnatal microcephaly (HP:0005484) | 2.09637282 |
| 98 | Delayed CNS myelination (HP:0002188) | 2.08806269 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 2.07828630 |
| 100 | Pulmonary infiltrates (HP:0002113) | 2.06973819 |
| 101 | Nephrogenic diabetes insipidus (HP:0009806) | 2.06215290 |
| 102 | Sensory axonal neuropathy (HP:0003390) | 2.05375393 |
| 103 | Prolonged bleeding time (HP:0003010) | 2.04128546 |
| 104 | Microvesicular hepatic steatosis (HP:0001414) | 2.03242384 |
| 105 | Gait imbalance (HP:0002141) | 2.02781620 |
| 106 | Leukocytosis (HP:0001974) | 2.02442873 |
| 107 | Respiratory failure (HP:0002878) | 2.01703494 |
| 108 | Abnormality of methionine metabolism (HP:0010901) | 2.01625506 |
| 109 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.01367553 |
| 110 | Vasculitis (HP:0002633) | 2.01025770 |
| 111 | Degeneration of anterior horn cells (HP:0002398) | 2.00220464 |
| 112 | Abnormality of the anterior horn cell (HP:0006802) | 2.00220464 |
| 113 | Exertional dyspnea (HP:0002875) | 1.99621558 |
| 114 | Abnormality of the pleura (HP:0002103) | 1.99303500 |
| 115 | Hyperglycinemia (HP:0002154) | 1.99275837 |
| 116 | Gastrointestinal infarctions (HP:0005244) | 1.99072595 |
| 117 | Hepatic necrosis (HP:0002605) | 1.96390254 |
| 118 | Increased muscle lipid content (HP:0009058) | 1.96179921 |
| 119 | Neoplasm of the adrenal gland (HP:0100631) | 1.93668208 |
| 120 | Microretrognathia (HP:0000308) | 1.92961118 |
| 121 | Neutropenia (HP:0001875) | 1.91732371 |
| 122 | Orchitis (HP:0100796) | 1.91696271 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91397844 |
| 124 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91397844 |
| 125 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91397844 |
| 126 | Premature rupture of membranes (HP:0001788) | 1.91306419 |
| 127 | Macrocytic anemia (HP:0001972) | 1.90927845 |
| 128 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90901269 |
| 129 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90901269 |
| 130 | Median cleft lip (HP:0000161) | 1.90670129 |
| 131 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.90268119 |
| 132 | Abnormality of T cells (HP:0002843) | 1.88586218 |
| 133 | Insidious onset (HP:0003587) | 1.88420307 |
| 134 | Termporal pattern (HP:0011008) | 1.88420307 |
| 135 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.87932153 |
| 136 | Polyphagia (HP:0002591) | 1.87536951 |
| 137 | Meckel diverticulum (HP:0002245) | 1.87439780 |
| 138 | Disinhibition (HP:0000734) | 1.87333417 |
| 139 | True hermaphroditism (HP:0010459) | 1.87082480 |
| 140 | Cellulitis (HP:0100658) | 1.86777181 |
| 141 | Genital tract atresia (HP:0001827) | 1.86697218 |
| 142 | Pancytopenia (HP:0001876) | 1.85804201 |
| 143 | Palpitations (HP:0001962) | 1.85465981 |
| 144 | Beaking of vertebral bodies (HP:0004568) | 1.85093980 |
| 145 | Hypoplastic pelvis (HP:0008839) | 1.84856304 |
| 146 | Urticaria (HP:0001025) | 1.84663510 |
| 147 | Poikiloderma (HP:0001029) | 1.82945115 |
| 148 | Neoplasm of the colon (HP:0100273) | 1.82411539 |
| 149 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.82280693 |
| 150 | Single umbilical artery (HP:0001195) | 1.82280693 |
| 151 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.82280693 |
| 152 | Lipid accumulation in hepatocytes (HP:0006561) | 1.82019133 |
| 153 | Abnormality of eosinophils (HP:0001879) | 1.81726427 |
| 154 | Stenosis of the external auditory canal (HP:0000402) | 1.80781387 |
| 155 | Stomatitis (HP:0010280) | 1.80672048 |
| 156 | Leukodystrophy (HP:0002415) | 1.80419062 |
| 157 | Methylmalonic acidemia (HP:0002912) | 1.80173806 |
| 158 | Recurrent cutaneous fungal infections (HP:0011370) | 1.78545777 |
| 159 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.78545777 |
| 160 | Lethargy (HP:0001254) | 1.78461219 |
| 161 | Abnormality of placental membranes (HP:0011409) | 1.77405645 |
| 162 | Amniotic constriction ring (HP:0009775) | 1.77405645 |
| 163 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.76898178 |
| 164 | Pancreatic fibrosis (HP:0100732) | 1.76087729 |
| 165 | Vaginal atresia (HP:0000148) | 1.76049708 |
| 166 | Abnormality of urine glucose concentration (HP:0011016) | 1.75907536 |
| 167 | Glycosuria (HP:0003076) | 1.75907536 |
| 168 | Optic disc pallor (HP:0000543) | 1.75891999 |
| 169 | Basal ganglia calcification (HP:0002135) | 1.75676254 |
| 170 | Generalized aminoaciduria (HP:0002909) | 1.75650619 |
| 171 | Abnormality of the ileum (HP:0001549) | 1.75496247 |
| 172 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75229995 |
| 173 | X-linked dominant inheritance (HP:0001423) | 1.75085630 |
| 174 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.74304781 |
| 175 | 11 pairs of ribs (HP:0000878) | 1.73993306 |
| 176 | Severe short stature (HP:0003510) | 1.73216054 |
| 177 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73081689 |
| 178 | CNS demyelination (HP:0007305) | 1.72648628 |
| 179 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.72573924 |
| 180 | Abnormality of chromosome stability (HP:0003220) | 1.72200933 |
| 181 | Increased intramyocellular lipid droplets (HP:0012240) | 1.72199632 |
| 182 | Neuroendocrine neoplasm (HP:0100634) | 1.71134374 |
| 183 | Adrenal hypoplasia (HP:0000835) | 1.70553324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.24761842 |
| 2 | TRIM28 | 3.75960167 |
| 3 | SCYL2 | 3.65327313 |
| 4 | STK16 | 3.58067728 |
| 5 | EIF2AK3 | 3.35945322 |
| 6 | BCR | 3.24375055 |
| 7 | MAP3K12 | 2.91364845 |
| 8 | ERBB3 | 2.77865616 |
| 9 | IRAK4 | 2.77037591 |
| 10 | PIM2 | 2.70595559 |
| 11 | NEK1 | 2.53595036 |
| 12 | PBK | 2.43949610 |
| 13 | TEC | 2.43385784 |
| 14 | TAOK3 | 2.35390509 |
| 15 | ERN1 | 2.31426301 |
| 16 | TESK1 | 2.29428225 |
| 17 | NME2 | 2.24504994 |
| 18 | WEE1 | 2.19189103 |
| 19 | TESK2 | 2.17602456 |
| 20 | RIPK4 | 2.03835445 |
| 21 | BLK | 1.97587517 |
| 22 | TRIB3 | 1.86847471 |
| 23 | PKN2 | 1.86015588 |
| 24 | CAMKK2 | 1.82820347 |
| 25 | MST1R | 1.80301644 |
| 26 | CDC7 | 1.76503057 |
| 27 | SIK3 | 1.71959186 |
| 28 | FES | 1.71697293 |
| 29 | WNK3 | 1.68935818 |
| 30 | KDR | 1.67785574 |
| 31 | PLK4 | 1.61712339 |
| 32 | VRK1 | 1.59036346 |
| 33 | BTK | 1.56940399 |
| 34 | MAP2K7 | 1.53188458 |
| 35 | MAP4K1 | 1.52446859 |
| 36 | PLK3 | 1.51526947 |
| 37 | KIT | 1.50581989 |
| 38 | MAP4K2 | 1.46995904 |
| 39 | EIF2AK1 | 1.45960613 |
| 40 | ACVR1B | 1.42128429 |
| 41 | ZAP70 | 1.38392453 |
| 42 | CSNK1A1L | 1.37015462 |
| 43 | DAPK1 | 1.35932273 |
| 44 | BRSK2 | 1.34876407 |
| 45 | CSNK1G3 | 1.34228345 |
| 46 | PLK2 | 1.33902532 |
| 47 | VRK2 | 1.33527874 |
| 48 | LIMK1 | 1.32863048 |
| 49 | TBK1 | 1.29168832 |
| 50 | NUAK1 | 1.29010602 |
| 51 | MAP3K11 | 1.27382175 |
| 52 | BUB1 | 1.25952068 |
| 53 | BCKDK | 1.25741514 |
| 54 | CSNK1G2 | 1.24317986 |
| 55 | SYK | 1.20865829 |
| 56 | CCNB1 | 1.20280824 |
| 57 | LRRK2 | 1.20163559 |
| 58 | STK39 | 1.17223576 |
| 59 | RAF1 | 1.16866404 |
| 60 | DYRK3 | 1.16639829 |
| 61 | EEF2K | 1.16156298 |
| 62 | TTK | 1.15429738 |
| 63 | MAP3K4 | 1.15385051 |
| 64 | ABL2 | 1.15242258 |
| 65 | GRK6 | 1.14508151 |
| 66 | RPS6KA4 | 1.09424447 |
| 67 | TSSK6 | 1.08757503 |
| 68 | CSNK1G1 | 1.05024713 |
| 69 | CDK8 | 1.04886831 |
| 70 | TYK2 | 1.04862392 |
| 71 | MKNK2 | 1.00639837 |
| 72 | ZAK | 0.98718541 |
| 73 | MAP2K3 | 0.97850156 |
| 74 | MAPKAPK3 | 0.96843254 |
| 75 | PAK4 | 0.96455515 |
| 76 | NEK2 | 0.94027300 |
| 77 | ILK | 0.93562785 |
| 78 | BMPR1B | 0.93295571 |
| 79 | FLT3 | 0.91784282 |
| 80 | MYLK | 0.91347429 |
| 81 | ERBB4 | 0.89681644 |
| 82 | MINK1 | 0.84338450 |
| 83 | MET | 0.83521973 |
| 84 | BMPR2 | 0.83228666 |
| 85 | JAK3 | 0.82172350 |
| 86 | ARAF | 0.79666932 |
| 87 | MAPK4 | 0.79417137 |
| 88 | CDK4 | 0.77956084 |
| 89 | PIM1 | 0.77887068 |
| 90 | MAPK13 | 0.77627984 |
| 91 | ATR | 0.76205966 |
| 92 | LYN | 0.74581808 |
| 93 | CAMKK1 | 0.71473247 |
| 94 | ITK | 0.71286496 |
| 95 | MAP3K8 | 0.71262140 |
| 96 | FGFR1 | 0.70814781 |
| 97 | MAP3K6 | 0.70638224 |
| 98 | CDK7 | 0.69897939 |
| 99 | BRSK1 | 0.69764014 |
| 100 | EIF2AK2 | 0.67071924 |
| 101 | CDK14 | 0.66821486 |
| 102 | MAP3K5 | 0.66024271 |
| 103 | STK3 | 0.62939857 |
| 104 | NME1 | 0.62496304 |
| 105 | STK38L | 0.62176025 |
| 106 | IRAK3 | 0.61282674 |
| 107 | PRKCE | 0.61173322 |
| 108 | CDK18 | 0.59121224 |
| 109 | JAK2 | 0.56456101 |
| 110 | AURKB | 0.54090069 |
| 111 | MATK | 0.53999610 |
| 112 | TLK1 | 0.53688668 |
| 113 | LCK | 0.53263863 |
| 114 | PIK3CG | 0.53232898 |
| 115 | DYRK2 | 0.52560166 |
| 116 | CDK19 | 0.52427003 |
| 117 | WNK4 | 0.50132010 |
| 118 | TNIK | 0.48890007 |
| 119 | MAP3K1 | 0.48367221 |
| 120 | STK24 | 0.48150937 |
| 121 | RPS6KB2 | 0.47969175 |
| 122 | CASK | 0.47944078 |
| 123 | PASK | 0.47489388 |
| 124 | OXSR1 | 0.47447754 |
| 125 | IKBKE | 0.47191522 |
| 126 | BRAF | 0.46850717 |
| 127 | CDK6 | 0.46495137 |
| 128 | EPHA2 | 0.46392447 |
| 129 | MAP3K14 | 0.44720304 |
| 130 | CDK15 | 0.43986516 |
| 131 | CDK11A | 0.43376809 |
| 132 | MARK1 | 0.42467972 |
| 133 | SRPK1 | 0.41992232 |
| 134 | PRKCI | 0.41355602 |
| 135 | HCK | 0.40695864 |
| 136 | RPS6KB1 | 0.39799038 |
| 137 | EPHB2 | 0.39757622 |
| 138 | PAK1 | 0.38926433 |
| 139 | MAP3K10 | 0.38856954 |
| 140 | AURKA | 0.38654847 |
| 141 | TAOK1 | 0.38487314 |
| 142 | PLK1 | 0.37469794 |
| 143 | TRPM7 | 0.37008419 |
| 144 | CHEK2 | 0.36848541 |
| 145 | CSNK2A1 | 0.36483949 |
| 146 | RIPK1 | 0.36266593 |
| 147 | HIPK2 | 0.34805413 |
| 148 | MKNK1 | 0.34296483 |
| 149 | PRKCD | 0.33553427 |
| 150 | PINK1 | 0.33433063 |
| 151 | CSF1R | 0.32955675 |
| 152 | EPHA4 | 0.32614835 |
| 153 | STK10 | 0.31976688 |
| 154 | LATS2 | 0.31966449 |
| 155 | MAPK11 | 0.31434208 |
| 156 | TGFBR1 | 0.31397082 |
| 157 | PAK6 | 0.31396701 |
| 158 | CSNK2A2 | 0.31038960 |
| 159 | KSR1 | 0.29622534 |
| 160 | ADRBK1 | 0.28565339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.43547554 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.57222555 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.55266260 |
| 4 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.70815641 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.45604046 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.41992189 |
| 7 | Basal transcription factors_Homo sapiens_hsa03022 | 2.30005380 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.28315047 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.15570086 |
| 10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.14890946 |
| 11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.13959120 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.13624767 |
| 13 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.04517027 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.96461733 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89034378 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84653218 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.80435365 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73596384 |
| 19 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.68926036 |
| 20 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.64466503 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.63149689 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61202301 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59318292 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.58637121 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.51042516 |
| 26 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.50459145 |
| 27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50270121 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42495618 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42337411 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41283020 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.40355510 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.40008141 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.38099160 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.35542058 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.35281828 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.33863875 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32825379 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.32794378 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.25505847 |
| 40 | Cell cycle_Homo sapiens_hsa04110 | 1.23484649 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22919380 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17663715 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17492864 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.16380177 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 1.16364400 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.14806601 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11865610 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 1.11228020 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10990843 |
| 50 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.10134489 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06724219 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06491006 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04740279 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.04720331 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99349926 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99296297 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97422525 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.97361751 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95123561 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.94188657 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93553060 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92991682 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92350093 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92062427 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91717097 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91476643 |
| 67 | * Lysosome_Homo sapiens_hsa04142 | 0.91409326 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.91338777 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89015575 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88709665 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.88649915 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87851175 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87434782 |
| 74 | RNA polymerase_Homo sapiens_hsa03020 | 0.86670324 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86088279 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.84573973 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83981925 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83070701 |
| 79 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.82506316 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.80854163 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80528131 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79246647 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77978515 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76562954 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75973289 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75105161 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.74479229 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74380395 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74198538 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.73684505 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73437273 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72546316 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71904912 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69319776 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68329885 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.68103819 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68040454 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66944890 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65858531 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63478431 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61867462 |
| 102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61361104 |
| 103 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61019106 |
| 104 | Purine metabolism_Homo sapiens_hsa00230 | 0.60472848 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59596381 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58267076 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.57822120 |
| 108 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57055365 |
| 109 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53516375 |
| 110 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53512140 |
| 111 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53307966 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53025048 |
| 113 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52735835 |
| 114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51540968 |
| 115 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50571303 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49241420 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48812394 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48738876 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48638812 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47913584 |
| 121 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46515471 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44803901 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44209329 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44004431 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41955095 |
| 126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41437732 |
| 127 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40903378 |
| 128 | Platelet activation_Homo sapiens_hsa04611 | 0.40774132 |
| 129 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.40506124 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40183841 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40039057 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38404880 |
| 133 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37201283 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37079111 |
| 135 | Malaria_Homo sapiens_hsa05144 | 0.35842990 |
| 136 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35644954 |
| 137 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35616846 |
| 138 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35116383 |
| 139 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35005497 |
| 140 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34168419 |
| 141 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33374224 |
| 142 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32487891 |
| 143 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.28012083 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26242372 |
| 145 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25167147 |
| 146 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23055267 |
| 147 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.18705064 |
| 148 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.17970288 |
| 149 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17607894 |

